Topline data from multiple Phase 2 studies expected throughout 2025
Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Seeking Alpha / 13 hours ago 2 Views
Seeking Alpha / 13 hours ago 2 Views
Topline data from multiple Phase 2 studies expected throughout 2025
Comments